http://www.zibb.com/all/theme/cq/Adams+Respiratory+Therapeutics+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Thu, 26 Nov 2009 19:45:09 GMTThu, 26 Nov 2009 19:45:09 GMT608831http://www.zibb.com/all/theme/cq/Adams+Respiratory+Therapeutics+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.adamslaboratories.com/Copyright © 2006 Adams Respiratory Therapeutics, Chester, NJ 07930. All rights reserved.http://www.adamslaboratories.com/Adams Respiratory Therapeutics Incorporatedhttp://www.tullisdickerson.com/newsevents.cfmNews & Announcements Events Tullis-Dickerson Press Contact Melanie Oldeman phone: 978.969.1895 email: moldeman@tullisdickerson.com Download Corporate Backgrounder News & Events December 2006 Adams Respiratory Therapeutics' Michael J. Valentino Elected Vice Chairman of the HealthCare Institute ofhttp://www.tullisdickerson.com/newsevents.cfmAdams Respiratory Therapeutics Incorporatedhttp://www.newratings.com/headlines/Adams-Respiratory-Therap-Inc-_US00635P1075.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/Adams-Respiratory-Therap-Inc-_US00635P1075.htmlAdams Respiratory Therapeutics Incorporatedhttp://www.ruderfinn.com/press_release.asp?release_id=107Pharmaceutical company Adams Respiratory Therapeutics announced today that Ruder Finn, Inc. has been chosen to represent the company on its corporate and marketing initiatives.http://www.ruderfinn.com/press_release.asp?release_id=107Adams Respiratory Therapeutics Incorporatedhttp://www.evaluatepharma.com/CoInfo/CoInfo-ARXT.htmEvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.http://www.evaluatepharma.com/CoInfo/CoInfo-ARXT.htmAdams Respiratory Therapeutics Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=52350Adams Respiratory Therapeutics is responsible for more productive coughs. Formerly known as Adams Laboratories, the firm makes over-the-counter remedies for respiratory ailments.http://www.pharmacychoice.com/News/article.cfm?Article_ID=52350Adams Respiratory Therapeutics Incorporatedhttp://www.newsrx.com/search_results.php?search_term=Adams%20Respiratory%20Therapeutics%20Inc&doSearch=SearchAdams argues that improved control of ammonia emissions from farm barnyards is more economical ... and nitrogen oxide pollution, Adams said.http://www.newsrx.com/search_results.php?search_term=Adams%20Respiratory%20Therapeutics%20Inc&doSearch=SearchAdams Respiratory Therapeutics Incorporatedhttp://www.ipohome.com/common/ipoprofile.asp?ticker=ARXTIPO Marketwatch IPO Plus Fund IPO Research IPO Newcomer Home Symbol or Name IPO Plus Fund Shareholder Login IPOhome User Registration Edit Profile Site Map Site Tour Privacy About Renaissance Capital Press Room Career Center Contact Us Adams Respiratory Therapeutics (ARXT) Business Business Marketshttp://www.ipohome.com/common/ipoprofile.asp?ticker=ARXTAdams Respiratory Therapeutics Incorporatedhttp://www.biospace.com/news_story.aspx?StoryID=26260&full=1CHESTER, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. today announced that it has completed its previously announced repurchase of the manufacturing assets and operations in Fort Worth, Texas, from Cardinal Health. As disclosed in an SEC filing on Aug.http://www.biospace.com/news_story.aspx?StoryID=26260&full=1Adams Respiratory Therapeutics Incorporatedhttp://www.prnewswire.com/cgi-bin/stories.pl?ACCT=ind_focus.story&STORY=/www/story/12-07-2006/0004487610&EDATE=THU+Dec+07+2006,+05:30+PMThe USPTO patent reexamination proceeding was previously disclosed in company press releases and in public filings with the Securities and Exchange Commission. In response to the Company's latest request for reconsideration, the USPTO continues to reject most of the claims of U.S. Patent No.http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=ind_focus.story&STORY=/www/story/12-07-2006/0004487610&EDATE=THU+Dec+07+2006,+05:30+PMAdams Respiratory Therapeutics Incorporatedhttp://www.buyandhold.com/StockMgr?request=display.content&symbol=ARXT&ContentURL=%2Fcustom%2Fbuyandhold%2Dcom%2Fhtml%2Dnews%2Easp&symb=ARXTCopyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by ComStock, an Interactive Data Company and subject to the Terms of Use.http://www.buyandhold.com/StockMgr?request=display.content&symbol=ARXT&ContentURL=%2Fcustom%2Fbuyandhold%2Dcom%2Fhtml%2Dnews%2Easp&symb=ARXTAdams Respiratory Therapeutics Incorporatedhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=26144&category=19Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=26144&category=19Adams Respiratory Therapeutics Incorporatedhttp://www.ucbpharma.com/media_centre/press_releases/medical/2006/Respiratory/UCB_sells_delsym_to_Adams_respiratory_therapeutics.aspBrussels (Belgium), 25 May 2006 - 8:00 am CET UCB S.A. announces today that it has reached an agreement with Adams Respiratory Therapeutics Inc. (NASDAQ: ARxT) to sell Delsym® (dextromethorphan polistirex), an over-the-counter (OTC) 12-hour liquid cough suppressant.http://www.ucbpharma.com/media_centre/press_releases/medical/2006/Respiratory/UCB_sells_delsym_to_Adams_respiratory_therapeutics.aspAdams Respiratory Therapeutics Incorporatedhttp://www.tullisdickerson.com/news_article.cfm?ID=722CHESTER, N.J., July 17 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. (Nasdaq: ARxT) today announced that it has received a commitment for a new five-year $50 million senior secured revolving credit facility from RBC Capital Markets.http://www.tullisdickerson.com/news_article.cfm?ID=722Adams Respiratory Therapeutics Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=33997Adams Respiratory Therapeutics knows mucus. Formerly known as Adams Laboratories, the firm makes over-the-counter remedies for respiratory ailments. The drugmaker's Mucinex-branded products are expectorants that rely on guaifenesin to help move excess mucus out of the body.http://www.pharmacychoice.com/News/article.cfm?Article_ID=33997Adams Respiratory Therapeutics Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=53864Commenting on the agreement, COO Robert D. Casale said, "This collaboration with MonoSol Rx offers Adams another platform technology -- oral thin-film drug delivery -- that can be used to further develop and expand our portfolio of prescription and OTC respiratory products.http://www.pharmacychoice.com/News/article.cfm?Article_ID=53864Adams Respiratory Therapeutics Incorporatedhttp://www.tullisdickerson.com/news_article.cfm?id=757&print_version=1He will also chair the Membership Committee of the board of trustees. Valentino has previously served HINJ as a board trustee for the past two years. Mr.http://www.tullisdickerson.com/news_article.cfm?id=757&print_version=1Adams Respiratory Therapeutics Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=37486District Court for the District of New Jersey against Mutual Pharmaceuticals Co. and United Research Laboratories, Inc. (URL), both wholly owned subsidiaries of Pharmaceutical Holdings Corp. for infringement of U.S. Patent No.http://www.pharmacychoice.com/News/article.cfm?Article_ID=37486Adams Respiratory Therapeutics Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=33937This company also claims that their application has been "accepted for filing," which means the FDA review process can begin. Adams has not yet been notified by the applicant of its Paragraph IV Certification, which is a requirement of the FDA filing.http://www.pharmacychoice.com/News/article.cfm?Article_ID=33937Adams Respiratory Therapeutics Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=51835. The PDUFA date is the date by which the FDA has set as a goal to review and act on the NDA submission. There is no guarantee that final marketing approval will be granted by the PDUFA date.http://www.pharmacychoice.com/News/article.cfm?Article_ID=51835Adams Respiratory Therapeutics Incorporatedhttp://www.adamslaboratories.com/phoenix.zhtml?c=189397&p=irol-govHighlightsSound corporate governance principles are the foundation of investor confidence and trust. These principles are critical to maintaining Adams Respiratory Therapeutics' reputation as a company dedicated to excellence in both performance and integrity.http://www.adamslaboratories.com/phoenix.zhtml?c=189397&p=irol-govHighlightsAdams Respiratory Therapeutics Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=53698For more detail about the information presented, please access the audio webcast and slides that accompany this meeting by going to the Investor Relations section of the Adams web site, http://www.adamsrt.com.http://www.pharmacychoice.com/News/article.cfm?Article_ID=53698Adams Respiratory Therapeutics Incorporatedhttp://www.adamslaboratories.com/phoenix.zhtml?c=189397&p=privacyAdams Respiratory Therapeutics Internet Privacy Statement Adams Respiratory Therapeutics is the owner of this site. This Privacy Statement is designed to tell you about our policy regarding the collection, use and/or disclosure of personal information from visitors to this site.http://www.adamslaboratories.com/phoenix.zhtml?c=189397&p=privacyAdams Respiratory Therapeutics Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=52683Adams Respiratory Therapeutics, Inc., a specialty pharmaceutical company, focuses on late-stage development, commercialization, and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.http://www.pharmacychoice.com/News/article.cfm?Article_ID=52683Adams Respiratory Therapeutics Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=48291Adams Respiratory Therapeutics is meaningfully mired in mucus. Formerly known as Adams Laboratories, the firm makes over-the-counter remedies for respiratory ailments. The drugmaker's Mucinex-branded products are expectorants that rely on guaifenesin to help move excess mucus out of the body.http://www.pharmacychoice.com/News/article.cfm?Article_ID=48291Adams Respiratory Therapeutics Incorporated